Valproic Acid-induced hyperammonemia in the elderly: a review of the literature
- PMID: 19724652
- PMCID: PMC2731545
- DOI: 10.1155/2009/802121
Valproic Acid-induced hyperammonemia in the elderly: a review of the literature
Abstract
Valproic acid and its derivatives are commonly used to treat many psychiatric conditions in the elderly. Hyperammonemia is a less common but important side effect of these drugs. The elderly patient appears highly vulnerable to this side effect of this group of medications. In this paper, we systematically review the published literature for hyperammonemia induced by valproic acid and its derivatives. We describe the three reported cases and review possible treatment strategies for this condition.
References
-
- Wadzinski J, Franks R, Roane D, Bayard M. Valproate-associated hyperammonemic encephalopathy. Journal of the American Board of Family Medicine. 2007;20(5):499–502. - PubMed
-
- Coulter DL, Wu H, Allen RJ. Valproic acid therapy in childhood epilepsy. Journal of the American Medical Association. 1980;244(8):785–788. - PubMed
-
- Lennkh C, Simhandl C. Current aspects of valproate in bipolar disorder. International Clinical Psychopharmacology. 2000;15(1):1–11. - PubMed
-
- Feil D, Chuang K, Sultzer DL. Valproate-induced hyperammonemia as a cause of altered mental status. American Journal of Geriatric Psychiatry. 2002;10(4):476–478. - PubMed
-
- Hamer HM, Knake S, Schomburg U, Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology. 2000;54(1):230–232. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
